Jay R. Venkatesan - 08 Apr 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Jay R. Venkatesan
Issuer symbol
SER
Transactions as of
08 Apr 2025
Net transactions value
+$500,000
Form type
4
Filing time
10 Apr 2025, 16:03:12 UTC
Previous filing
13 Feb 2025
Next filing
20 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Series A Convertible Preferred Stock Award $500,000 +96,525 $5.18 96,525 08 Apr 2025 Common Stock, $0.0001 par value 96,525 $5.18 The Jay Venkatesan Legacy Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Convertible Preferred Stock is perpetual and therefore has no expiration date.